Preventive Regimen of Immunostimulants Within Personalised “3S” Paradigm of Anticancer Drug Testing

EPMA Journal - United Kingdom
doi 10.1186/1878-5085-5-s1-a35
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nutrigenetic Testing and Personalised Nutrition: A Qualitative Study

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2011English

Magnetic Control of the Anticancer Drug

Journal of the Magnetics Society of Japan
1980English

Role of Plants in Anticancer Drug Discovery

Phytochemistry Letters
BiochemistryPlant ScienceAgronomyCrop ScienceBiotechnology
2014English

Efficacy of Four Drug Regimen vs. Three Drug Regimen in Patients of Tuberculous Lymphadenitis, Registered at S.N Medical College, Agra

Journal of Medical Science And clinical Research
2018English

Dendrimers for Drug Delivery of Anticancer Drugs

2015English

Anticancer Drug-Phospholipid Conjugate for Enhancement of Intracellular Drug Delivery

Macromolecular Symposia
Organic ChemistryPolymersMaterials ChemistryCondensed Matter PhysicsPlastics
2007English

The Impact of Formulation, Delivery, and Dosing Regimen on the Risk of Drug–Drug Interactions

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Role of mTOR in Anticancer Drug Resistance: Perspectives for Improved Drug Treatment

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2008English

Transcription Factor-Based Drug Design in Anticancer Drug Development

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy